Source Repros Therapeutics Inc.$ 2.3 billion debate over the fiscal year limit 2007 Appropriations Bill; final vote Likely On WednesdayThe Senate on Tuesday voted 71-26 the debate on a the debate over a $ 463,000 in fiscal year 2007 omnibus Budget Management that more funds for health programs, including, a final vote expected on Wednesday, the AP / Washington Times reports . A spokesman for Senate Majority Leader Harry Reid . Courtesy of you, the entire Kaiser Daily Health Policy view Report, search the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supports kaiser network a free service of The Henry J.
Presentednd endometriosis.rom FDA on Clinical Hold Status Of Proellex Repros Therapeutics Inc. today announced that a conference call was held with the FDA to review the clinical hold status Proelle. Earlier clinical trials were findings findings of changes in liver enzymes at higher doses of oral drugs in serious adverse events. Proellex being being investigated as a treatment for fibroids and endometriosis. – In a press release by the Company on Published April 2013, presented reproductions, that they requested the FDA lift the clinical hold, so ask the company to a single parallel design study to determine whether lower doses would be safe and would effectively. Continue reading Source Repros Therapeutics Inc.